about
Inhibition of microglial inflammatory responses by norepinephrine: effects on nitric oxide and interleukin-1beta productionMonocytes from depressed patients display an altered pattern of response to endotoxin challengeInvolvement of mTOR kinase in cytokine-dependent microglial activation and cell proliferationDetection of HLA-B*57:01 by real-time PCR: implementation into routine clinical practice and additional validation data.Proinflammatory-activated glioma cells induce a switch in microglial polarization and activation status, from a predominant M2b phenotype to a mixture of M1 and M2a/B polarized cells.The mTOR kinase inhibitor rapamycin decreases iNOS mRNA stability in astrocytes.Noradrenergic regulation of inflammatory gene expression in brain.mTOR kinase: a possible pharmacological target in the management of chronic pain.Intrinsic regulation of brain inflammatory responses.Receptor-independent actions of PPAR thiazolidinedione agonists: is mitochondrial function the key?The novel HSP90 inhibitor, PU-H71, suppresses glial cell activation but weakly affects clinical signs of EAE.Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology.mTOR kinase, a key player in the regulation of glial functions: relevance for the therapy of multiple sclerosis.Modulatory effects of the CCR5 antagonist maraviroc on microglial pro-inflammatory activation elicited by gp120.The activation of type 1 corticotropin releasing factor receptor (CRF-R1) inhibits proliferation and promotes differentiation of neuroblastoma cells in vitro via p27(Kip1) protein up-regulation and c-Myc mRNA down-regulation.Lovastatin and mevastatin reduce basal and cytokine-stimulated production of prostaglandins from rat microglial cells in vitro: evidence for a mechanism unrelated to the inhibition of hydroxy-methyl-glutaryl CoA reductase.Diverging effects of cortistatin and somatostatin on the production and release of prostanoids from rat cortical microglia and astrocytes.Endocrine disruptors and human reproductive failure: the in vitro effect of phthalates on human luteal cells.The mTOR kinase inhibitors polarize glioma-activated microglia to express a M1 phenotype.Endocrine disruptors and human corpus luteum: in vitro effects of phenols on luteal cells function.HIV-1 Gp120 protein modulates corticotropin releasing factor synthesis and release via the stimulation of its mRNA from the rat hypothalamus in vitro: involvement of inducible nitric oxide synthase.Buprenorphine inhibits bradykinin-induced release of calcitonin gene-related peptide from rat trigeminal neurons via both mu-opioid and nociceptin/orphanin peptide receptors.Novel sensitive, specific and rapid pharmacogenomic test for the prediction of abacavir hypersensitivity reaction: HLA-B*57:01 detection by real-time PCR.Primary cultures of microglial cells for testing toxicity of anticancer drugs.Antiretroviral agents increase NO production in gp120/IFNγ-stimulated cultures of rat microglia via an arginase-dependent mechanism.Trigeminal satellite cells modulate neuronal responses to triptans: relevance for migraine therapy.Norepinephrine protects cortical neurons against microglial-induced cell death.Erythropoietin exerts anti-apoptotic effects on rat microglial cells in vitro.The human microglial HMC3 cell line: where do we stand? A systematic literature reviewTrigeminal satellite cells express functional calcitonin gene-related peptide receptors, whose activation enhances interleukin-1β pro-inflammatory effectsEvidence that hydrogen sulphide can modulate hypothalamo-pituitary-adrenal axis function: in vitro and in vivo studies in the ratThe heat-shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin suppresses glial inflammatory responses and ameliorates experimental autoimmune encephalomyelitisNociceptin (1-13)NH2 inhibits stimulated calcitonin-gene-related-peptide release from primary cultures of rat trigeminal ganglia neurones
P50
Q24796356-E6682B28-7F09-408C-8AE2-84198E775E9DQ28484837-31D161DD-94FF-4CB9-97C0-1A9E4F7F8C3DQ28571967-26D8945C-0C6D-4619-8094-A5F3C9E8BB11Q30758299-46016A44-7644-4B6A-9B26-5F3F368BB6F0Q33580909-A0C397B0-346B-4020-8687-FF62F4C571ABQ34515338-25CD744F-F042-4955-825A-B9CBC37B5CA7Q34784409-D950374F-EB88-44EE-B2CB-5C038FBC234AQ35035474-F611DADC-7CEE-4CAB-BE6F-EA71C3FA7621Q35545545-2C67CC91-3A52-4AB3-9B34-822B2839053EQ36144641-3B17788F-D208-4458-BD07-F02EEF7F0F8EQ37010253-EC8C49DA-B3A0-47A0-BDF4-D21367F34147Q37318028-D9C70B77-F5A6-403A-AF21-9AC4B5A407DFQ38050335-36A950B6-D45C-414B-902F-B8A8D4F3CE1EQ38330960-D815EFDC-4F59-4079-86DB-E100AD0A2423Q38876975-A0AED060-2D1D-4558-AA14-352C3E8F5088Q42454907-7A7E6891-5A17-41C6-A429-1A3D0DEEDAB3Q42455984-10600383-DA34-43E5-8C06-EB7332AB3478Q42462029-BB5D5FBD-A05B-447A-AB4A-0C6A42C70BBBQ42462727-55C6F05C-14EB-49F8-B0DE-7B8E2368DD48Q42711267-9006D4C5-81DE-4AC3-BB96-B155747BDAC3Q43702850-66955DEB-96BE-4511-8B54-3DA1837E94E6Q44341909-FF7ACAD8-3EFE-4C19-A89F-13E0993014C3Q44393316-C3A7E0A9-979C-47A4-AF12-D01A9B0FF603Q44798564-966592E8-ED65-4438-8F64-43BA5D548E2AQ46080976-EF1D37BA-103D-4C86-A2F2-912926CAE735Q46495708-AEDF6BC2-1B95-4E9C-9569-802A258F0739Q46538600-320EA7FF-40A7-4DC1-AF7F-4A4AA54FA3D1Q48482743-0784FD72-45CD-4369-AB6D-BCDB081C4829Q58755718-767F64F0-CA11-472D-9241-0FB66368DD76Q59706143-6D3FC89D-1FFE-4327-8C56-561240CB279FQ73552635-24D07F9C-3C6E-46CA-8709-B4CAE394937AQ79299817-F5E30BF2-BFB9-4261-BABD-DA3AF4EE0056Q80639722-9D426F33-8773-4391-8C19-9CF6C354B649
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Cinzia Dello Russo
@ast
Cinzia Dello Russo
@en
Cinzia Dello Russo
@es
Cinzia Dello Russo
@nl
type
label
Cinzia Dello Russo
@ast
Cinzia Dello Russo
@en
Cinzia Dello Russo
@es
Cinzia Dello Russo
@nl
prefLabel
Cinzia Dello Russo
@ast
Cinzia Dello Russo
@en
Cinzia Dello Russo
@es
Cinzia Dello Russo
@nl
P106
P1153
6603166119
P31
P496
0000-0002-2538-3832